Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)

A. Sureda; A. Engert; P. J. Browett; J. A. Radford; G. E. Verhoef; R. Ramchandren; N. Myke; A. Shen; C. Le Corre; A. Younes

Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)

A. Sureda, A. Engert, P. J. Browett, J. A. Radford, G. E. Verhoef, R. Ramchandren, N. Myke, A. Shen, C. Le Corre, A. Younes

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	Undefined
Article number	8007
Journal	Journal of Clinical Oncology
Volume	28
Issue number	15 Supplement 5
Publication status	Published - 20 May 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Sureda, A., Engert, A., Browett, P. J., Radford, J. A., Verhoef, G. E., Ramchandren, R., Myke, N., Shen, A., Le Corre, C., & Younes, A. (2010). Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT). Journal of Clinical Oncology, 28(15 Supplement 5), Article 8007.

@article{6babfbb139e9461da53fabb232576996,

title = "Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)",

author = "A. Sureda and A. Engert and Browett, {P. J.} and Radford, {J. A.} and Verhoef, {G. E.} and R. Ramchandren and N. Myke and A. Shen and {Le Corre}, C. and A. Younes",

year = "2010",

month = may,

day = "20",

language = "Undefined",

volume = "28",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins",

number = "15 Supplement 5",

}

Sureda, A, Engert, A, Browett, PJ, Radford, JA, Verhoef, GE, Ramchandren, R, Myke, N, Shen, A, Le Corre, C & Younes, A 2010, 'Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)', Journal of Clinical Oncology, vol. 28, no. 15 Supplement 5, 8007.

Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT). / Sureda, A.; Engert, A.; Browett, P. J. et al.
In: Journal of Clinical Oncology, Vol. 28, No. 15 Supplement 5, 8007, 20.05.2010.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)

AU - Sureda, A.

AU - Engert, A.

AU - Browett, P. J.

AU - Radford, J. A.

AU - Verhoef, G. E.

AU - Ramchandren, R.

AU - Myke, N.

AU - Shen, A.

AU - Le Corre, C.

AU - Younes, A.

PY - 2010/5/20

Y1 - 2010/5/20

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000208852005027&KeyUID=WOS:000208852005027

M3 - Meeting Abstract

SN - 0732-183X

VL - 28

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15 Supplement 5

M1 - 8007

ER -

Interim results for the phase II study of panobinostat (LBH589) in patients (Pts) with relapsed/refractory Hodgkin's lymphoma (HL) after autologous hematopoietic stem cell transplant (AHSCT)

UN SDGs

Other files and links

Cite this